17β-hydroxysteroid dehydrogenase type 11 (Pan1b) expression in human prostate cancer

Neoplasma

Volumn 56, Issue 4, 2009, Pages 317-320

  Nakamura, Y ^a   Suzuki, T ^a   Arai, Y ^a   Sasano, H ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

17 hydroxysteroid dehydrogenase type XI; Immunochemistry; Prostate cancer

Indexed keywords

17BETA HYDROXYSTEROID DEHYDROGENASE 11; ANDROGEN; ANDROSTANEDIOL; ENZYME; UNCLASSIFIED DRUG; ALDEHYDE DEHYDROGENASE; ANDROGEN RECEPTOR; AR PROTEIN, HUMAN; ESTROGEN RECEPTOR BETA; HSD17B11 PROTEIN, HUMAN; HYDROXYSTEROID DEHYDROGENASE; KI 67 ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ANDROGEN METABOLISM; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; PROSTATECTOMY; SEMINAL VESICLE;

17-HYDROXYSTEROID DEHYDROGENASES; AGED; ALDEHYDE OXIDOREDUCTASES; ESTROGEN RECEPTOR BETA; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SEMINAL VESICLES;

EID: 68149122351     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_04_317     Document Type: Article

References (15)

1. López-Otín C, Diamandis EP. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr Rev 1998; 19: 365-396. doi: 10.1210/er.19.4.365
2. Nakamura Y, Suzuki T, Nakabayashi M et al. In situ androgen producing enzymes in human prostate cancer. Endocr Relat Cancer 12 2005; 12: 101-107.
3. Negri-Cesi P, Poletti A, Colciago A et al. Presence of 5alpha-reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue. Prostate 1998; 34: 283-291. doi:10.1002/(SICI)1097- 0045(19980301)34:4<283:: AID-PROS6>3.0.CO;2-I
4. Brereton P, Suzuki T, Sasano H et al. Pan1b (17betaHSD11)-enzymatic activity and distribution in the lung. Mol Cell Endocrinol 2001; 171: 111-117. doi:10.1016/S0303-7207(00)00417-2
5. Chai Z, Brereton P, Suzuki T et al. 17 beta-hydroxysteroid dehydrogenase type XI localizes to human steroidogenic cells. Endocrinology 2003; 144:2084-2091. doi:10.1210/en.2002- 221030
6. Laplante Y, Poirier D. Proliferative effect of androst-4-ene-3,17- -dione and its metabolites in the androgen-sensitive LNCaP cell line. Steroids 2008; 72: 266-271. doi:10.1016/j.steroids. 2007.10.009
7. Nakamura Y, Suzuki T, Fukuda T et al. Steroid sulfatase and estrogen sulfotransferase in human prostate cancer. Prostate 2006; 66: 1005-1012. doi:10.1002/pros.20426
8. Suzuki T, Darnel AD, Akahira JI et al. 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions. J Clin Endocrinol Metab 2001; 86: 2250-2257. doi: 10.1210/jc.86.5.2250
9. Hiramatsu M, Maehara I, Ozaki M et al. Aromatase in hyperplasia and carcinoma of the human prostate. Prostate 1997; 31: 118-124. doi:10.1002/(SICI)1097-0045(19970501)31:2<118:: AID-PROS7>3.0.CO;2-J
10. Rizner TL, Lin HK, Peehl DM et al. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. Endocrinology 2003; 144: 2922-2932. doi:10.1210/en.2002-0032
11. Ji Q, Chang L, VanDenBerg D et al. Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. Prostate 2003; 54: 275-289. doi:10.1002/pros.10192
12. Potter SR, Epstein JI, Partin AW. Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications. Rev Urol 2000; 2: 190-195.
13. Li SC, Chen GF, Chan PS et al. Altered expression of extracellular matrix and proteinases in Noble rat prostate gland after long- -term treatment with sex steroids. Prostate 2001; 49: 58-71. doi:10.1002/pros.1118
14. Tchédam-Ngatcha B, Luu-The V, Poirier D. Androsterone derivatives substituted at position 16: chemical synthesis, inhibition of type 3 17beta-hydroxysteroid dehydrogenase, binding affinity for steroid receptors and proliferative/antiproliferative activity on Shionogi (AR+) cells. J Enzyme Inhib Med Chem 2002; 17: 155-165. doi:10.1080/1475636021000002067
15. Yang Q, Titus MA, Fung KM et al. 5alpha-androstan e - 3 alpha , 17 beta - diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: Implication of androgen-independent prostate cancer progression. J Cell Biochem 2008; 104: 1612-1624. doi:10.1002/jcb.21731 PMid:18320593